Claris Biotherapeutics is developing ocular biologic solution for the treatment of neurotrophic keratitis. The company is headquartered in Jersey City, New Jersey, the US. For a complete picture of ...
The first medical cure of a corneal infection due to an Acanthamoeba species is reported. The 44-year-old patient developed a suppurative keratitis associated with an epithelial defect, hypopyon, and ...
The European Commission has approved SIFI's Akantior as the first therapy anywhere in the world for acanthamoeba keratitis (AK), an ultra-rare parasitic infection that can lead to blindness.
1 Department of Infectious and Tropical Diseases, Clinical Research Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK Background: A multicentre study was carried ...
1 Department of Ophthalmology, The China-Japan Union Hospital of Jilin University, Changchun, Jilin, China 2 Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin, ...
To compare safety, efficacy and cost–effectiveness of voriconazole with natamycin, a double-blinded RCT was conducted in two hospitals in India in 2010. The design was superior to antecedent ...